Dendritic Cell-based Immunotherapy for Rheumatoid Arthritis: from Bench to Bedside

키워드

참고문헌 (69)

1. Hilkens, C. M., "Tolerogenic dendritic cell therapy for rheumatoid arthritis: where are we now?", Clin. Exp. Immunol, 172, pp.148~157 (2013)
2. Choy, E. H., "The problem of choice: current biologic agents and future prospects in RA", Nat. Rev. Rheumatol, 9, pp.154~163 (2013)
3. Singh, J. A., "Biologics for rheumatoid arthritis: an overview of Cochrane reviews", Cochrane Database Syst. Rev, pp.CD007848~ (2009)
4. Stoop, J. N., "Developing tolerogenic dendritic cell therapy for rheumatoid arthritis: what can we learn from mouse models?", Ann. Rheum. Dis, 70, pp.1526~1533 (2011)
5. Steinman, R. M., "Decisions about dendritic cells: past, present, and future", Annu. Rev. Immunol, 30, pp.1~22 (2012)
6. Steinman, R. M., "Avoiding horror autotoxicus: the importance of dendritic cells in peripheral T cell tolerance", Proc. Natl. Acad. Sci. U. S. A, 99, pp.351~358 (2002)
7. Jonuleit, H., "Dendritic cells as a tool to induce anergic and regulatory T cells", Trends Immunol, 22, pp.394~400 (2001)
8. Yamazaki, S., "Dendritic cells expand antigen-specific Foxp3＋CD25＋CD4＋regulatory T cells including suppressors of alloreactivity", Immunol. Rev, 212, pp.314~329 (2006)
9. Roncarolo, M. G., "Differentiation of T regulatory cells by immature dendritic cells", J. Exp. Med, 193, pp.F5~F9 (2001)
10. Voigtlander, C., "Dendritic cells matured with TNF can be further activated in vitro and after subcutaneous injection in vivo which converts their tolerogenicity into immunogenicity", J. Immunother, 29, pp.407~415 (2006)
11. Kleindienst, P., "Simultaneous induction of CD4 T cell tolerance and CD8 T cell immunity by semimature dendritic cells", J. Immunol, 174, pp.3941~3947 (2005)
12. Rutella, S., "Tolerogenic dendritic cells: cytokine modulation comes of age", Blood, 108, pp.1435~1440 (2006)
13. Harden, J. L., "Indoleamine 2,3-dioxygenase and dendritic cell tolerogenicity", Immunol. Invest, 41, pp.738~764 (2012)
14. Quaratino, S., "Fully competent dendritic cells as inducers of T cell anergy in autoimmunity", Proc. Natl. Acad. Sci. U. S. A, 97, pp.10911~10916 (2000)
15. Lutz, M. B., "Therapeutic potential of semi-mature dendritic cells for tolerance induction", Front. Immunol, 3, pp.123~ (2012)
16. Bianco, N. R., "Therapeutic effect of exosomes from indoleamine 2,3-dioxygenase-positive dendritic cells in collagen-induced arthritis and delayed-type hypersensitivity disease models", Arthritis Rheum, 60, pp.380~389 (2009)
17. Kim, S. H., "Effective treatment of established mouse collagen-induced arthritis by systemic administration of dendritic cells genetically modified to express FasL", Mol. Ther, 6, pp.584~590 (2002)
18. Yang, J., "LF15-0195 generates tolerogenic dendritic cells by suppression of NF-kappaB signaling through inhibition of IKK activity", J. Leukoc. Biol, 74, pp.438~447 (2003)
19. Menges, M., "Repetitive injections of dendritic cells matured with tumor necrosis factor alpha induce antigen-specific protection of mice from autoimmunity", J. Exp. Med, 195, pp.15~21 (2002)
20. Lim, D. S., "Semimature DC are immunogenic and not tolerogenic when inoculated at a high dose in collagen-induced arthritis mice", Eur. J. Immunol, 39, pp.1334~1343 (2009)
21. Sakaguchi, S., "Regulatory T cells: key controllers of immunologic self-tolerance", Cell, 101, pp.455~458 (2000)
22. Bach, J. F., "Regulatory T cells under scrutiny", Nat. Rev. Immunol, 3, pp.189~198 (2003)
23. Fontenot, J. D., "Foxp3programs the development and function of CD4＋CD25＋regulatory T cells", Nat. Immunol, 4, pp.330~336 (2003)
24. Khattri, R., "An essential role for Scurfin in CD4＋CD25＋T regulatory cells", Nat. Immunol, 4, pp.337~342 (2003)
25. Buckner, J. H., "Mechanisms of impaired regulation by CD4(＋)CD25(＋)FOXP3(＋) regulatory T cells in human autoimmune diseases", Nat. Rev. Immunol, 10, pp.849~859 (2010)
26. Thomson, A. W., "Tolerogenic dendritic cells for autoimmune disease and transplantation", Ann. Rheum. Dis, 67(Suppl 3), pp.iii90~iii96 (2008)
27. Zheng, J., "MicroRNA-23b promotes tolerogenic properties of dendritic cells in vitro through inhibiting Notch1", NF-kappaB signalling pathways, 2012, pp.67, 362~370
28. Stumpfova, Z., "MicroRNA profiling of activated and tolerogenic human dendritic cells", Mediators Inflamm, 2014, pp.259689~ (2014)
29. Valencia, J., "Wnt5a skews dendritic cell differentiation to an unconventional phenotype with tolerogenic features", J. Immunol, 187, pp.4129~4139 (2011)
30. Zhu, B., "IL-4 and retinoic acid synergistically induce regulatory dendritic cells expressing Aldh1a2", J. Immunol, 191, pp.3139~3151 (2013)
31. Steinbrink, K., "Induction of tolerance by IL-10-treated dendritic cells", J. Immunol, 159, pp.4772~4780 (1997)
32. Yarilin, D., "Dendritic cells exposed in vitro to TGF-beta1 ameliorate experimental autoimmune myasthenia gravis", Clin. Exp. Immunol, 127, pp.214~219 (2002)
33. Boks, M. A., "IL-10-generated tolerogenic dendritic cells are optimal for functional regulatory T cell induction--a comparative study of human clinical-applicable DC", Clin. Immunol, 142, pp.332~342 (2012)
34. Turnquist, H. R., "Rapamycin-conditioned dendritic cells are poor stimulators of allogeneic CD4＋T cells, but enrich for antigen-specific Foxp3＋T regulatory cells and promote organ transplant tolerance", J. Immunol, 178, pp.7018~7031 (2007)
35. Pothoven, K. L., "Rapamycinconditioned donor dendritic cells differentiate CD4CD25Foxp3 T cells in vitro with TGF-beta1 for islet transplantation", Am. J. Transplant, 10, pp.1774~1784 (2010)
36. Salazar, L., "Modulation of established murine collagen-induced arthritis by a single inoculation of short-term lipopolysaccharide-stimulated dendritic cells", Ann. Rheum. Dis, 67, pp.1235~1241 (2008)
37. van der, K. D., "A novel host-parasite lipid cross-talk. Schistosomal lyso-phosphatidylserine activates toll-like receptor 2 and affects immune polarization", J. Biol. Chem, 277, pp.48122~48129 (2002)
38. Maldonado, R. A., "How tolerogenic dendritic cells induce regulatory T cells", Adv. Immunol, 108, pp.111~165 (2010)
39. Roncarolo, M. G., "Interleukin-10-secreting type 1 regulatory T cells in rodents and humans", Immunol. Rev, 212, pp.28~50 (2006)
40. Papatriantafyllou, M., "Tolerance: both natural and induced TReg talents needed", Nat. Rev. Immunol, 11, pp.500~ (2011)
41. Qureshi, O. S., "Trans-endocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4", Science, 332, pp.600~603 (2011)
42. Gregori, S., "The cellular and molecular mechanisms of immuno-suppression by human type 1 regulatory T cells", Front. Immunol, 3, pp.30~ (2012)
43. Mellor, A. L., "Cutting edge: induced indoleamine 2,3 dioxygenase expression in dendritic cell subsets suppresses T cell clonal expansion", J. Immunol, 171, pp.1652~1655 (2003)
44. Coombes, J. L., "A functionally specialized population of mucosal CD103＋DCs induces Foxp3＋regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism", J. Exp. Med, 204, pp.1757~1764 (2007)
45. Sun, C. M., "Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid", J. Exp. Med, 204, pp.1775~1785 (2007)
46. Ocadlikova, D., "CD103 marks a subset of human CD34＋-derived langerin ＋dendritic cells that induce T-regulatory cells via indoleamine 2,3-dioxygenase-1", Exp. Hematol, 43, pp.268~276 (2015)
47. Paidassi, H., "Preferential expression of integrin alphavbeta8 promotes generation of regulatory T cells by mouse CD103＋dendritic cells", Gastroenterology, 141, pp.1813~1820 (2011)
48. Goubier, A., "Plasmacytoid dendritic cells mediate oral tolerance", Immunity, 29, pp.464~475 (2008)
49. Faunce, D. E., "Cutting edge: in vitro-generated tolerogenic APC induce CD8＋T regulatory cells that can suppress ongoing experimental autoimmune encephalomyelitis", J. Immunol, 172, pp.1991~1995 (2004)
50. Harry, R. A., "Generation and characterisation of therapeutic tolerogenic dendritic cells for rheumatoid arthritis", Ann. Rheum. Dis, 69, pp.2042~2050 (2010)
51. Sato, K., "Matsuyama. 2003. Regulatory dendritic cells protect mice from murine acute graft-versus-host disease and leukemia relapse", Immunity, 18, pp.367~379 (2003)
52. Gangi, E., "IL-10-producing CD4＋CD25＋regulatory T cells play a critical role in granulocyte-macrophage colony-stimulating factor-induced suppression of experimental autoimmune thyroiditis", J. Immunol, 174, pp.7006~7013 (2005)
53. Ferreira, G. B., "1,25-Dihydroxyvitamin D3 promotes tolerogenic dendritic cells with functional migratory properties in NOD mice", J. Immunol, 192, pp.4210~4220 (2014)
54. Adorini, L., "Tolerogenic dendritic cells induced by vitamin D receptor ligands enhance regulatory T cells inhibiting autoimmune diabetes", Ann. N. Y. Acad. Sci, 987, pp.258~261 (2003)
55. Diana, J., "Crosstalk between neutrophils, B-1a cells and plasmacytoid dendritic cells initiates autoimmune diabetes", Nat. Med, 19, pp.65~73 (2013)
56. Li, Q., "Interferon-alpha initiates type 1 diabetes in nonobese diabetic mice", Proc. Natl. Acad. Sci. U. S. A, 105, pp.12439~12444 (2008)
57. Park, J. E., "DC-Based Immunotherapy Combined with Low-Dose Methotrexate Effective in the Treatment of Advanced CIA in Mice", J. Immunol. Res, 2015, pp.834085~ (2015)
58. Zhang, L., "Bone marrow CD11b(＋)F4", 80(＋) dendritic cells ameliorate collagen-induced arthritis through modulating the balance between Treg and Th17, 2015, pp.25, 96~105
59. Ren, Y., "Tolerogenic dendritic cells modified by tacrolimus suppress CD4(＋) T-cell proliferation and inhibit collagen-induced arthritis in mice", Int. Immunopharmacol, 21, pp.247~254 (2014)
60. Li, X., "Apigenin, a potent suppressor of dendritic cell maturation and migration, protects against collagen-induced arthritis", J. Cell. Mol. Med, 20, pp.170~180 (2016)
61. Yang, J., "A mouse model of adoptive immunotherapeutic targeting of autoimmune arthritis using allo-tolerogenic dendritic cells", PLoS One, 8, pp.e77729~ (2013)
62. Thomas, R., "Safety and preliminary evidence of efficacy in a phase I clinical trial of autologous tolerizing dendritic cells exposed to citrullinated peptides (Rheumavax)in patients with rheumatoid arthritis", Ann. Rheum. Dis, 70, pp.169~ (2011)
63. Benham, H., "Citrullinated peptide dendritic cell immunotherapy in HLA risk genotype-positive rheumatoid arthritis patients", Sci. Transl. Med, 7, pp.290ra87~ (2015)
64. Buckland, J., "Rheumatoid arthritis: First-in-human phase I trial of DC immunotherapy for early RA", Nat. Rev. Rheumatol, 11, pp.443~ (2015)
65. Lim, D. S., "Semi-mature DC are immunogenic and not tolerogenic when inoculated at a high dose in collagen-induced arthritis mice", Eur. J. Immunol, 39, pp.1334~1343 (2009)
66. Martin, E., "Antigen-specific suppression of established arthritis in mice by dendritic cells deficient in NF-kappaB", Arthritis Rheum, 56, pp.2255~2266 (2007)
67. Stoop, J. N., "Therapeutic effect of tolerogenic dendritic cells in established collagen-induced arthritis is associated with a reduction in Th17 responses", Arthritis Rheum, 62, pp.3656~3665 (2010)
68. Nielen, M. M., "Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors", Arthritis Rheum, 50, pp.380~386 (2004)
69. Isaacs, J. D., "The changing face of rheumatoid arthritis: sustained remission for all?", Nat. Rev. Immunol, 10, pp.605~611 (2010)

관련 논문AI추천